LDL Particle Number counts the total number of LDL particles directly using NMR spectroscopy, rather than measuring the cholesterol content inside them. It's reported in nmol/L and provides the same fundamental insight as ApoB, a particle count rather than cholesterol mass.
Two people with identical LDL cholesterol can have very different LDL particle numbers, and the person with more particles carries higher cardiovascular risk regardless of their LDL-C. This marker is especially valuable when LDL-C appears normal but metabolic dysfunction is suspected. It often reveals the "atherogenic discordance" pattern where particle count tells a different story than cholesterol mass.
Optimal LDL Particle Number: 0-700 nmol/L.
Typically re-tested every 12 weeks.
Because particle size and cholesterol content vary from person to person, this count can tell a different story than a standard cholesterol panel. The sections below explain the biology, the ranges, and what a high or low result may reflect.
LDL particle number is a laboratory count of how many low-density lipoprotein particles are circulating in a blood sample, reported as a concentration in nanomoles per litre (nmol/L).
Cholesterol does not dissolve in blood, so the body packages it into lipoproteins. LDL particles are the main vehicles that carry cholesterol out to tissues. Each one is a sphere of fat and protein containing cholesterol, cholesteryl esters, triglyceride and phospholipid, wrapped around a single structural protein called apolipoprotein B 2. Because the ratio is one apolipoprotein B molecule per particle, counting particles and counting that protein are closely related ways of asking the same question.
The key point is that the vehicles are not identical. Some LDL particles are large and cholesterol-rich; others are small and relatively cholesterol-poor. Laboratory methods that separate lipoproteins into subclasses, such as nuclear magnetic resonance spectroscopy and ion mobility, were developed precisely because the cholesterol carried inside LDL and the number of particles carrying it do not always move together 1.
That gap has a name. When LDL cholesterol sits in one risk category and particle number sits in another, labs and clinicians describe the result as discordant. A person eating a low-carbohydrate diet, or a person with insulin resistance, may show a modest LDL cholesterol value while carrying a larger number of smaller particles to move that same cholesterol. An LDL particle number test is one of the ways to see that pattern rather than infer it.
It matters because atherosclerosis begins with particles crossing into the artery wall, and the number of particles influences how often that can happen.
The arterial lining is semi-permeable. LDL particles small enough to pass through can become trapped in the sub-endothelial space, where they may be oxidised or otherwise modified and taken up by immune cells, forming the early fatty streak. Modified forms of LDL, including the electronegative subfraction, have been studied as active participants in this process rather than passive bystanders, though researchers continue to debate how much is cause and how much is consequence 5.
Reviews of vascular prevention markers suggest that particle-based measures such as apolipoprotein B and LDL particle number track cardiovascular risk at least as closely as LDL cholesterol, and can add information when the two disagree 3. That is the practical argument for measuring the count rather than only the cargo.
Discordance is not rare. A joint expert review of obesity, dyslipidemia and cardiovascular disease describes how excess adiposity and insulin resistance shift lipoprotein metabolism toward more triglyceride-rich particles, smaller denser LDL and a higher particle count, often while LDL cholesterol itself looks unremarkable 4. In that setting, a reassuring cholesterol panel may understate what is happening.
None of this makes a single number predictive on its own. These risk patterns describe populations over years, not what will happen to one person. LDL particle number is one input into a longer conversation that also includes blood pressure, glucose regulation, inflammation, family history and lipoprotein(a).
Most labs report LDL particle number against a reference interval of roughly 0 to 1000 nmol/L, and FitScript uses a tighter optimal range of 0 to 700 nmol/L.
| Measure | Range (nmol/L) | How to read it |
|---|---|---|
| Standard lab reference range | 0 to 1000 | The typical reference interval reported on a lab result |
| FitScript optimal range | 0 to 700 | An optimization target, narrower than the reference interval |
Typical lab reference ranges vary by laboratory, assay method, age and sex, so always read your result against the interval printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and no range is supplied here split by sex or by age, so none is implied.
Two practical notes. First, particle counts from different methods are not perfectly interchangeable, so tracking a trend works best when the same lab and method are used each time. Second, a result inside the reference interval is not automatically ideal for a given person, and a result outside it is not automatically a disease. Both are observations to interpret in context.
A high result means more LDL particles were circulating when the blood was drawn, which is associated with greater opportunity for particles to enter and accumulate in the artery wall.
Symptoms people report. Usually none. Elevated particle number produces no sensation, no fatigue signature and no reliable physical sign, which is why it is found on testing rather than noticed. The exception is marked inherited elevation. In people with familial hypercholesterolemia, long-standing lipid elevation can produce visible deposits such as tendon xanthomas, xanthelasma around the eyelids or a corneal arcus appearing at an unusually young age, and the condition is frequently under-recognised until a cardiovascular event or a family screening brings it to light 6.
Common causes. Inherited lipid disorders sit at one end, with familial hypercholesterolemia the best characterised 6. Far more common are the metabolic contributors. Excess visceral fat and insulin resistance shift particle metabolism toward higher counts of smaller particles 4. Dietary pattern, physical inactivity, hypothyroidism, kidney disease, pregnancy and certain medications can all move lipid handling. Cholestatic liver conditions are a distinctive cause; a systematic review of primary biliary cirrhosis found that marked hyperlipidemia is characteristic of the condition while the associated atherosclerotic risk appeared less straightforward than the lipid numbers alone would imply 7.
One pattern deserves its own line, because it confuses people. A high LDL particle number with low triglycerides is a recognised combination, often seen in lean, metabolically healthy people and in some people eating very low-carbohydrate diets. Low triglycerides and a favourable HDL value are genuinely reassuring signals about metabolic health, but they do not cancel out a high particle count, and the two findings are worth discussing together rather than letting one override the other.
Long-term impact. Across populations, higher particle-based lipid measures are associated with greater long-term atherosclerotic burden, which is why prevention reviews give them weight alongside standard cholesterol values 3. The useful next step after a high result is not alarm. It is repeat testing to confirm, a look at apolipoprotein B, lipoprotein(a), glucose regulation and inflammatory markers, and a conversation with a clinician about overall risk.
A low LDL particle number means relatively few LDL particles were circulating, which is generally regarded as a favourable finding for cardiovascular risk.
Symptoms people report. Typically none. A low count is not something people feel. Where symptoms exist, they usually belong to whatever is driving the low value rather than to the value itself, for example the digestive symptoms, weight change or nutrient issues that can accompany malabsorption, or the symptoms of an overactive thyroid.
Common causes. Lipid-lowering medication is the most frequent explanation, since the main classes lower circulating particle counts as well as cholesterol. Genetic causes exist too, including familial hypobetalipoproteinemia, in which apolipoprotein B production is reduced. Other contributors include hyperthyroidism, malabsorption, advanced liver disease, significant undernutrition, and acute illness or inflammation, which can transiently depress lipid values.
Long-term impact. A low particle number achieved through diet, body composition and medication is associated with lower atherosclerotic risk in the research literature 3. A persistently very low or falling result with no obvious explanation is a different situation and is worth discussing with a clinician promptly, because the question then is what is driving it. Discordance works in this direction as well. A low particle count alongside high triglycerides, or alongside a low HDL value, still describes a lipoprotein profile worth examining as a whole rather than marker by marker 1.
Particle number responds to testing conditions, medications and habits, and it moves meaningfully over weeks to months rather than overnight.
Testing conditions. Fasting status matters less for particle counts than for triglycerides, but labs still have their own collection instructions, so follow the ones you are given. Acute illness, infection, recent surgery, hard unaccustomed exercise in the days before the draw, pregnancy, and rapid weight change can all shift lipoprotein metabolism temporarily. Assay method matters too, so compare like with like when tracking a trend.
Medications. Several drug classes influence particle number through different mechanisms, and the direction and size of the effect depends on the individual. Bile acid sequestrants work in the gut rather than the liver; a trial of colesevelam in hypercholesterolemia reported a reduction in LDL particle number alongside an increase in average LDL size 10. SGLT-2 inhibitors, used mainly for glucose control, have been reported to produce modest and somewhat mixed changes across lipid fractions 11. Cholesteryl ester transfer protein is the enzyme that exchanges cholesteryl esters and triglycerides between lipoproteins, and inhibiting it reshapes the distribution of cholesterol across particles, an approach that remains an active area of structural and clinical research 12. No dosing or administration guidance belongs in an article like this one. A licensed provider evaluates whether any prescription option is appropriate for a particular person.
Habits. Dietary fat quality is the most studied lever. A randomized cross-over study found that saturated fat, rather than dietary cholesterol from eggs, was the larger driver of LDL cholesterol levels, which is a useful corrective to the idea that cholesterol in food is the main variable 8. Plant sterols and stanols reduce intestinal cholesterol absorption and have been studied for their effects on lipoprotein metabolism, with research suggesting modest LDL reductions when intake is consistent 9. Viscous fibre, fish and plant sources of unsaturated fat, regular aerobic and resistance training, reduced visceral fat, moderated alcohol intake and not smoking all sit in the same broad category of changes that may support a more favourable lipoprotein profile. In people with insulin resistance, improving glucose handling and body composition often does more for particle number than any single food swap 4.
FitScript does not currently test LDL particle number in a panel, so this marker is read from labs you already hold.
If a previous panel included an LDL-P result, you can upload it and have Atlas, FitScript's AI health advisor, read it alongside the rest of your biology rather than in isolation. That is the part most people are missing. A particle count means something quite different next to a high triglyceride value, a low HDL value and a rising fasting insulin than it does next to a clean metabolic picture and a strong family history.
Membership covers 150+ biomarkers tested per year, and Atlas writes your FitScript from those results, the markers you upload, and what you report about training, sleep and nutrition. Where a result raises a question that needs a prescription answer, a licensed provider reviews your case and decides whether any therapy is appropriate. Nothing in a lab report, on its own, makes that decision.
Particle number is best interpreted as part of a lipid panel, not as a standalone verdict.
Apolipoprotein B is the closest companion, since each atherogenic particle carries one molecule of it, which makes apolipoprotein B a widely available stand-in for particle burden 2. LDL Cholesterol tells you how much cholesterol those particles are carrying, and the comparison between the two is where discordance becomes visible. Cholesterol - Total gives the overall pool across all lipoproteins and is the number most people have on file already. HDL Cholesterol reflects a different arm of cholesterol transport, and the Cholesterol / HDL Ratio packages the relationship between the two pools into one trackable figure. Triglycerides round out the picture, because triglyceride-rich lipoproteins feed directly into the remodelling that produces smaller, denser LDL particles 4. Lipoprotein(a) and high sensitivity C-reactive protein are also frequently discussed alongside particle measures in vascular prevention reviews 3. Readers who already have results sitting in an old portal can upload your existing labs so the whole set is read together.
Related: Is HDL Plus LDL Total Cholesterol? (Not Quite, Here's Why)
Treat the number as a starting question rather than an answer. Confirm it with a repeat test under similar conditions, look at it next to apolipoprotein B, triglycerides, HDL and your glucose markers, and note anything in the weeks before the draw that could have shifted it. Then take the full set to a clinician or licensed provider who can place it against your personal and family history and decide, with you, whether anything should change.
This article is educational and is not medical advice.
It measures how many low-density lipoprotein particles are circulating in a blood sample, reported in nmol/L. LDL cholesterol measures the cargo inside those particles; particle number counts the particles themselves. Because particle size and cholesterol content vary, the two values can disagree in the same person.
Labs commonly report a reference interval of roughly 0 to 1000 nmol/L, and FitScript uses an optimal range of 0 to 700 nmol/L as an optimization target rather than a diagnostic cut-off. Reference intervals vary by laboratory, assay method, age and sex, so read your result against the range printed on your own report.
It means more LDL particles were circulating at the time of the draw, which is associated with greater long-term atherosclerotic risk across populations. It is an observation, not a diagnosis. The sensible next steps are a confirmatory repeat test, a look at apolipoprotein B and your metabolic markers, and a conversation with a clinician about your overall risk.
Yes, and this is the main reason the test exists. When particles are smaller and more numerous, the same amount of cholesterol can be distributed across many more vehicles. Lab methods that separate lipoprotein subclasses were developed partly because cholesterol content and particle count do not always move together.
It is a recognised combination, often seen in lean, metabolically healthy people and in some people following very low-carbohydrate diets. Low triglycerides are a genuinely favourable metabolic signal, but they do not offset a high particle count. Both findings belong in the same conversation with a clinician rather than one cancelling the other.
There is no single answer, and no article can set one for an individual. Nutrition quality, body composition, physical activity, glucose regulation, alcohol and smoking all influence lipoprotein metabolism. Several medication classes also lower particle counts through different mechanisms. A licensed provider evaluates whether any prescription option is appropriate after reviewing the full picture.
A low count is generally regarded as favourable, particularly when it follows diet, training or lipid-lowering medication. A persistently very low or unexplained falling result is different, since causes can include hyperthyroidism, malabsorption, liver disease or acute illness, and that pattern is worth discussing with a clinician promptly.
Particle number shifts over weeks to months rather than days, so retesting is usually scheduled after a meaningful change in nutrition, body composition or medication rather than on a short cycle. Using the same lab and assay method each time makes the trend far easier to read than isolated values from different sources.
FitScript does not currently include LDL particle number in a panel. Members who already have a result from previous bloodwork can upload those labs so Atlas, FitScript's AI health advisor, reads the value alongside their other markers instead of in isolation.